Weekly Recap: Rebecca Hall named CFO and R&D seminars with 5—6% spend

Hikma Pharmaceuticals Plc Sponsored GDR RegS (LSE:HIK) named Rebecca Hall as CFO and executive director starting Q1 2027 with Khalid Nabilsi leaving the board Dec 31, 2026 while Areb Kurdi remains acting CFO; the company plans R&D spend of ~5—6% of revenue, will hold R&D investor seminars and issue…